번호 | 종목명 | 밸류 스코어 |
주가 | 배당금 | 시총 | PER | PBR | ROE | DY ▼ | 52주 가격범위 |
---|---|---|---|---|---|---|---|---|---|---|
1 | 일성신약 | 61.2 | 27,550 | 4,000 | 3,664 | 3.0 | 0.86 | 28.14% | 23.70% |
![]() 14,440 38,000 |
2 | JB금융지주 | 71.2 | 8,530 | 835 | 16,803 | 2.8 | 0.37 | 13.13% | 10.58% |
![]() 6,880 11,160 |
3 | ○○○○ | 80.7 | 10,240 | 960 | 81,656 | 2.9 | 0.28 | 9.58% | 9.78% |
![]() 8,780 11,300 |
4 | ○○○○○○○ | 65.7 | 6,780 | 625 | 22,098 | 2.7 | 0.22 | 8.20% | 9.62% |
![]() 5,960 7,840 |
5 | ○○○○○○○ | 61.7 | 7,060 | 650 | 11,942 | 3.0 | 0.22 | 7.46% | 9.30% |
![]() 6,630 8,730 |
6 | ○○○○○○○○ | 63.7 | 4,430 | 400 | 800 | 10.7 | 0.90 | 8.43% | 8.86% |
![]() 4,220 7,130 |
7 | ○○○○ | 83.4 | 30,150 | 2,500 | 34,931 | 5.6 | 0.44 | 7.89% | 8.46% |
![]() 28,550 33,950 |
8 | ○○○○○○ | 71.6 | 41,650 | 3,350 | 123,244 | 3.5 | 0.34 | 9.75% | 7.97% |
![]() 33,200 53,300 |
9 | ○○ | 75.4 | 50,800 | 3,600 | 3,485 | 1.7 | 0.22 | 13.33% | 7.92% |
![]() 41,600 53,000 |
10 | ○○○○○ | 77.5 | 229,000 | 18,000 | 2,977 | 10.6 | 3.00 | 28.16% | 7.71% |
![]() 227,500 258,500 |
11 | ○○○○ | 80.3 | 55,500 | 4,000 | 5,209 | 8.9 | 0.38 | 4.24% | 7.17% |
![]() 51,800 60,700 |
12 | ○○○○○○ | 64.7 | 77,800 | 4,600 | 55,082 | 5.6 | 1.02 | 18.29% | 7.04% |
![]() 52,800 87,400 |
13 | ○○○○ | 72.8 | 228,000 | 13,800 | 108,015 | 8.4 | 0.98 | 11.62% | 6.90% |
![]() 183,500 239,500 |
14 | ○○○○○ | 81.1 | 33,900 | 2,200 | 2,697 | 4.7 | 0.34 | 7.34% | 6.88% |
![]() 31,050 38,350 |
15 | ○○○○ | 77.2 | 9,160 | 600 | 889 | 17.8 | 0.83 | 4.68% | 6.86% |
![]() 8,330 10,800 |
16 | ○○○○ | 64.4 | 33,100 | 1,965 | 29,591 | 5.2 | 0.70 | 13.60% | 6.67% |
![]() 28,100 38,700 |
17 | ○○○ | 78.3 | 7,470 | 500 | 3,735 | 9.3 | 2.38 | 25.69% | 6.56% |
![]() 6,700 9,800 |
18 | ○○○○ | 82.9 | 7,240 | 430 | 10,196 | 6.5 | 0.36 | 5.60% | 6.31% |
![]() 6,112 8,330 |
19 | ○○○○○○ | 65.2 | 59,100 | 3,500 | 15,248 | 5.1 | 0.64 | 12.63% | 6.17% |
![]() 51,800 85,300 |
20 | ○○○○○○○○○ | 70.8 | 12,520 | 600 | 8,252 | 5.0 | 0.29 | 5.77% | 6.00% |
![]() 9,290 13,800 |
「열린보도원칙」 당 매체는 독자와 취재원 등 뉴스이용자의 권리 보장을 위해 반론이나 정정보도, 추후보도를 요청할 수 있는 창구를 열어두고 있음을 알려드립니다.